UBS Group’s SeaStar Medical ICU Stock Holding History
Bought
Maintained
Sold
Other funds holding ICU
TRCT
NA
UBS Group's ICU Position: Q2 2026 in Review
UBS Group increased its SeaStar Medical (ICU) stake by 3,859% in Q2 2026, buying an estimated $116K and bringing the position to 31,398 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #7105.
UBS Group first reported a position in ICU in Q1 2021 and has held it in 17 quarters since. The position peaked at $221K in Q2 2024. 18 funds tracked by Wall St. Rank hold ICU as of Q2 2026.
- UBS Group held 31,398 shares of SeaStar Medical worth $115K as of Q2 2026.
- UBS Group bought 30,605 SeaStar Medical shares in Q2 2026, an estimated $116K.
- SeaStar Medical made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7105 holding.
- UBS Group first reported a position in SeaStar Medical in Q1 2021 and has held it in 17 quarters since.
- UBS Group's SeaStar Medical position peaked at $221K in Q2 2024.
- 18 funds tracked by Wall St. Rank held SeaStar Medical as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.